Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(3):e18–114.
2. Passacquale G, Sharma P, Perera D, et al. Antiplatelet therapy in cardiovascular disease: current status and future directions. Br J Clin Pharmacol. 2022;88(6):2686–99.
3. Rodriguez F, Harrington RA. Management of antithrombotic therapy after acute coronary syndromes. N Engl J Med. 2021;384(5):452–60.
4. Tao L, Ren S, Zhang L, et al. A review of the role of the antiplatelet drug ticagrelor in the management of acute coronary syndrome, acute thrombotic disease, and other diseases. Med Sci Monit. 2022;28: e935664.
5. Degrauwe S, Pilgrim T, Aminian A, et al. Dual antiplatelet therapy for secondary prevention of coronary artery disease. Open Heart. 2017;4(2): e000651.